Moderna and MSD begin trial of mRNA-4157 and Keytruda combination for lung cancer
INTerpath-009 is a global, randomised, double-blind trial that will involve 680 participants.
Trilink Thematic mRNA WP
Moderna’s norovirus vaccine enters Phase III trials in the UK
mRNA licensing agreements surge 800% amid GSK lawsuits
Transgene’s stock drops after Phase II cancer jab trial misses primary endpoint
Moderna doses first subject in Phase III trial of mRNA norovirus vaccine in US
mRNA Covid-19 vaccines may boost cancer immunotherapy effectiveness
ESMO 2024: Moderna’s mRNA solid tumour vaccine shows early promise
GSK reports positive interim data from mRNA influenza vaccine trial
